Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Completed · Phase 3
Conditions studied: Breast Cancer
In brief
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using triptorelin, exemestane, and tamoxifen may fight breast cancer by blocking the use of estrogen. It is not yet known whether giving triptorelin together with exemestane is more effective than triptorelin and tamoxifen in treating hormone-responsive breast cancer. PURPOSE: This randomized phase III trial is studying triptorelin and exemestane to see how well they work compared to triptorelin and tamoxifen in treating premenopausal women with hormone-responsive breast cancer.
Key facts
- Study ID
- NCT00066703
- Run by
- ETOP IBCSG Partners Foundation
- People needed
- 2672
- Starts
- 2003-11-03
- Expected to finish
- 2024-10-23
- Last updated by the study team
- 2026-02-06
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
- Providence Holy Cross Cancer Center — Mission Hills, California, United States
- Desert Regional Medical Center Comprehensive Cancer Center — Palm Springs, California, United States
- Sutter Cancer Center at Roseville Medical Center — Roseville, California, United States
- Sutter Cancer Center — Sacramento, California, United States
- Mercy General Hospital — Sacramento, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
- Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital — Whittier, California, United States
- University of Colorado Cancer Center at UC Health Sciences Center — Aurora, Colorado, United States
- Shaw Regional Cancer Center — Edwards, Colorado, United States
- Poudre Valley Hospital — Fort Collins, Colorado, United States
- Front Range Cancer Specialists — Fort Collins, Colorado, United States
- Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center — Farmington, Connecticut, United States
- Sibley Memorial Hospital — Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
- Northeast Georgia Medical Center — Gainesville, Georgia, United States
- Mountain States Tumor Institute at St. Luke's Regional Medical Center — Boise, Idaho, United States
- Kootenai Cancer Center - Coeur d'Alene — Coeur d'Alene, Idaho, United States
- Resurrection Medical Center — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute — Decatur, Illinois, United States
- Evanston Hospital — Evanston, Illinois, United States
- CCOP - Carle Cancer Center — Urbana, Illinois, United States
- Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center — Burbank, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.